Active Substance & Generic Molecule Directory
Mupirocin in Malaysia: Registered Brands, Dosages & Price Comparison
Directory of all approved pharmaceutical brands containing Mupirocin registered with the National Pharmaceutical Regulatory Agency (NPRA) / Ministry of Health Malaysia (KKM).
11
Registered Brands
Availability in Malaysia:11 Prescription (MAL-A)
Showing 11 of 11 registered brands
| MAL Reg No | Brand Formulation Name | Strength / Dosage | Classification | Registration Holder | Action |
|---|---|---|---|---|---|
| MAL25106015AZ | BACOREN Mupirocin Ointment BP 2.0 % w/w | 20.00 mg 1.00 gm | Prescription (MAL-A) | Synercam (M) Sdn Bhd | Compare → |
| MAL19096024AZ | BACTOPIC (MUPIROCIN OINTMENT 2%) | 2.0 %w/w | Prescription (MAL-A) | SYNERRV SDN BHD | Compare → |
| MAL20061550AZ | BACTRICIN OINTMENT 2%W/W | 20MG/G | Prescription (MAL-A) | SM PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL24056087AZ | DERMOCIN (Mupirocin Ointment BP 2.0% W/W) | 0.020 gm 1 gm | Prescription (MAL-A) | HEALOL PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL23036019AZ | MUODERM (Mupirocin 2%w/w Ointment) | 0.3 gm 15 gm | Prescription (MAL-A) | HEALOL PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL09051555AZ | Mupicin ointment 2%w/w | 2 %(w/w) | Prescription (MAL-A) | PRIME PHARMACEUTICAL SDN. BHD. | Compare → |
| MAL05121148AZ | Muposten Ointment 2%w/w | 20.00 mg 1 g | Prescription (MAL-A) | STERILINE SDN. BHD. | Compare → |
| MAL20061516AZ | MUPRIN OINTMENT | 2.0% W/W | Prescription (MAL-A) | HOE PHARMACEUTICALS SDN. BHD. | Compare → |
| MAL08010699AZ | MUROZIN OINTMENT 2% W/W | 2.15 %(w/w) | Prescription (MAL-A) | Abio Marketing Sdn Bhd | Compare → |
| MAL20076047AZ | PIROBACT (Mupirocin Ointment USP 2% w/w) | 20 mg/g | Prescription (MAL-A) | Synergy Meditech (M) Sdn Bhd | Compare → |
| MAL06081211AZ | Supirocin Ointment | 2 %(w/w) 0 | Prescription (MAL-A) | Glenmark Pharmaceuticals (Malaysia) Sdn. Bhd. | Compare → |
Generic Bioequivalence & Drug Substitution in Malaysia
Generic medications registered under NPRA contain the identical active pharmaceutical ingredient (API) in identical dosage strength and route of administration as the originator brand. NPRA requires rigorous bioequivalence (BE) studies demonstrating that generic drugs deliver the exact therapeutic effect. Always confirm with your doctor or community pharmacist before switching between prescription brands.